Back to PRICE T ROWE ASSOCIATES INC /MD/ PRICE T ROWE ASSOCIATES INC /MD/

TVTXTVTX
19 quarters

Position history for PRICE T ROWE ASSOCIATES INC /MD/PRICE T ROWE ASSOCIATES INC /MD/'s holdings in TRAVERE THERAPEUTICS INC

Yes. Price T Rowe Associates holds 1,318,616 shares of TVTX (Travere Therapeutics), worth $74.9M, as of its Q2 2026 13F filing. It increased the position from 404,805 shares in Q1 2026. Price T Rowe Associates has held TVTX since Q4 2021, across 19 quarterly 13F filings.

Current Value

$74.9M

Current Shares

1.3M

Total Value Change

+$74.5M

Total Shares Change

+1.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.3M
+225.7%
$74.9M0.0%$56.81
48
2026-Q1
Increased
404,805
+2.5%
$12M0.0%$29.71
29
2025-Q4
Increased
394,844
+397.0%
$15.1M0.0%$38.21
45
2025-Q3
Increased
79,444
+11.3%
$1.9M0.0%$23.90
29
2025-Q2
Increased
71,372
+33.9%
$1.1M0.0%$14.80
32
2025-Q1
Increased
53,309
+34.6%
$956,0000.0%$17.92
32
2024-Q4
Decreased
39,604
-85.9%
$690,0000.0%$17.42
0
2024-Q3
Increased
281,349
+741.3%
$3.9M0.0%$13.99
43
2024-Q2
Increased
33,441
+7.8%
$275,0000.0%$8.22
17
2024-Q1
Increased
31,009
+10.5%
$240,0000.0%$7.71
17
2023-Q4
Increased
28,061
+4.6%
$253,0000.0%$8.99
17
2023-Q3
Decreased
26,832
-27.8%
$240,0000.0%$8.94
0
2023-Q2
Increased
37,151
+18.7%
$571,0000.0%$15.36
29
2023-Q1
Increased
31,290
+7.9%
$704,0000.0%$22.49
27
2022-Q4
Decreased
28,998
-6.4%
$610,0000.0%$21.03
0
2022-Q3
Increased
30,974
+15.3%
$764,0000.0%$24.64
28
2022-Q2
Increased
26,868
+63.0%
$651,0000.0%$24.23
36
2022-Q1
Increased
16,486
+16.1%
$425,0000.0%$25.77
19
2021-Q4
New
14,197
-
$441,0000.0%$31.04
37

Other major holders of TVTX: Jupiter Topco LLC, BlackRock, Inc., FMR LLC, Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used